Glenn Wilkins - Thursday, May 31, 2018 Aptose Biosciences Inc. 10:48 AM EST - Aptose Biosciences Inc. : Has entered into a Common Share Purchase Agreement of up to $20 Million U.S. with Aspire Capital Fund, LLC. Aptose Biosciences Inc. shares T.APS are trading down $0.08 at $4.63.